GlassScriptPhysician profile
Modupe D Mcintosh
NPI 1174522916
$1,085.78
in general payments reported to CMS, 2019-2025
10 companies · $988 in 2025
The $988 reported for 2025 was more than what 80% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.45 · 2022: $24.87 · 2023: $17.06 · 2024: $40.94 · 2025: $988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,046.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $577.50 | 2025 | Auvelity |
| Abbvie INC. | $202.13 | 2025 | |
| Noven Therapeutics, LLC | $152.87 | 2025 | Xelstrym, Secuado |
| Neurocrine Biosciences, INC. | $39.43 | 2025 | |
| Jazz Pharmaceuticals INC. | $24.87 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.15 | 2024 | Trintellix |
| Ironshore Pharmaceuticals INC. | $17.79 | 2024 | |
| Janssen Biotech, INC. | $17.06 | 2023 | Tecvayli, Darzalex |
| Corium, LLC | $16.53 | 2025 | Azstarys |
| Astellas Pharma US INC | $14.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Modupe Mcintosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.